Calcium signalling remodelling and disease

Biochemical Society Transactions

Volumn 40, Issue 2, 2012, Pages 297-309

  Berridge, Michael J ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

Alzheimer's disease; Bipolar disorder; Calcium; Heart; Inositol; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM CHANNEL; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; CALCIUM CHANNEL R TYPE; CALCIUM CHANNEL T TYPE; CALCIUM ION; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; G PROTEIN COUPLED RECEPTOR; GLYCOGEN SYNTHASE KINASE 3BETA; INOSITOL 1,4,5 TRISPHOSPHATE; INTERLEUKIN 6; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; RYANODINE RECEPTOR; STAT PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT; TYROSINE KINASE RECEPTOR;

ALZHEIMER DISEASE; APOPTOSIS; BIPOLAR DISORDER; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL SURVIVAL; ENDOPLASMIC RETICULUM; ENZYME INHIBITION; HEART ATRIUM ARRHYTHMIA; HEART HYPERTROPHY; HUMAN; INTERNEURON; INTRACELLULAR SIGNALING; LONG TERM DEPRESSION; LONG TERM POTENTIATION; NERVE CELL; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SCHIZOPHRENIA;

BUFFERS; CALCIUM CHANNELS; CALCIUM SIGNALING; DISEASE; HUMANS; PHENOTYPE; RECEPTORS, CELL SURFACE;

EID: 84859313330     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20110766     Document Type: Review

References (62)

1. Berridge, M.J., Lipp, P. and Bootman, M.D. (2000) The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 1, 11-21
2. Berridge, M.J., Bootman, M.D. and Roderick, H.L. (2003) Calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 4, 517-529
3. Hamilton, S.L. (2005) Ryanodine receptors. Cell Calcium 38, 253-260
4. 2+ release channels. Physiol. Rev. 87, 593-658
5. 2+ signaling in health and disease. Biochem. J. 439, 349-374
6. 2+ buffers. Cell. Mol. Life Sci. 66, 275-300
7. Baughman, J.M., Perocchi, F., Girgis, H.S., Plovanich, M., Belcher-Timme, C.A., Sancack, Y., Bao, R., Strittmatter, L., Goldberger, O., Boborad, R.L. et al. (2011) Intergrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter. Nature 476, 341-345
8. De Stafani, D., Raffaelio, A., Teardo, E., Szabo, I. and Rizzuto, R. (2011) A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature 476, 336-340
9. Deng, X., Wang, Y., Zhou, Y., Soboloff, J. and Gill, D.L. (2009) STIM and Orai: dynamic intermembrane coupling to control cellular calcium signals. J. Biol. Chem. 284, 22501-22505
10. 2+ channel. Circ. Res. 90, 174-181
11. Carafoli, E. and Brini, M. (2007) Calcium Signalling and Disease, Springer, Berlin
12. MacKenzie, L., Bootman, M.D., Berridge, M.J. and Lipp, P. (2001) Predetermined recruitment of calcium release sites underlies excitation-contraction coupling in rat atrial myocytes. J. Physiol. 530, 417-429 (Pubitemid 32162330)
13. 2+ signalling and the generation of arrhythmias in rat atrial myocytes. J. Physiol. 541, 395-409
14. Mackenzie, L., Roderick, H.L., Berridge, M.J., Conway, S.J. and Bootman, M.D. (2004) The spatial pattern of atrial cardiomyocyte calcium signalling modulates contraction. J. Cell Sci. 117, 6327-6337 (Pubitemid 40214560)
15. Kockskämper, J., Zima, A.V., Roderick, H.L., Pieske, B., Blatter, L.A. and Bootman, M.D. (2008) Emerging roles of inositol 1,4,5-trisphosphate signalling in cardiac myocytes. J. Mol. Cell. Cardiol. 45, 128-147
16. Proven, A., Roderick, H.L., Conway, S.J., Berridge, M.J., Horton, J.K., Capper, S.J. and Bootman, M.D. (2006) Inositol 1,4,5-trisphosphate supports the arrhythmogenic action of endothelin-1 on ventricular cardiac myocytes. J. Cell Sci. 119, 3363-3375
17. Berridge, M.J. (2003) Cardiac calcium signalling. Biochem. Soc. Trans. 31, 930-933
18. 2+ signaling in cardiac myocyte excitation-transcription coupling. J. Clin. Invest. 116, 675-682
19. 2+ in the heart: contraction versus intracellular signaling. J. Clin. Invest. 116, 623-626
20. 2+ signalling systems and cardiac hypertrophy. Biochem. Soc. Trans. 34, 228-231
21. Berridge, M.J. (2006) Calcium microdomains: organization and function. Cell Calcium 40, 405-412
22. 2+ signals. Circ. Res. 109, 512-523
23. 2+ sparks and waves mediated by inositol 1,4,5-trisphosphate receptors in neonatal rat cardiomyocytes. Cell Calcium 43, 165-174
24. 2+ transients and arrhythmias associated with cardiac hypertrophy. Proc. Natl. Acad. Sci. U.S.A. 106, 11406-11411
25. 2+ release is a nexus for hypertrophic signalling in cardiac myocytes. Mol. Cell 33, 472-482
26. 3 receptor regulates cardiac hypertrophy in response to select stimuli. Circ. Res. 107, 659-666
27. Berridge, M.J. (1998) Neural calcium signalling. Neuron 21, 13-26
28. LaFerla, F.M. (2002) Calcium dyshomeostasis and intracellular signaling in Alzheimer's disease. Nat. Rev. Neurosci. 3, 862-872
29. Stutzmann, G.E. (2007) The pathogenesis of Alzheimer's disease: is it a lifelong "calciumopathy". Neuroscientist 13, 546-559
30. Kuchibhotla, K.V., Goldman, S.T., Lattarulo, C.R., Wu, H.-Y., Hyman, B.T. and Bacskai, B.J. (2008) Aâ plaques lead to aberrant regulation of neuronal networks. Neuron 59, 214-225
31. Cheung, K.-H., Shineman, D., Müller, M., Cárdenas, C., Mei, L., Yang, J., Tomita, T., Iwatsubo, T., Lee, V.M. and Foskett, J.K. (2008) Mechanisms of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating. Neuron 58, 871-883 (Pubitemid 351842747)
32. 2+ signaling. Proc. Natl. Acad. Sci. U.S.A. 108, 13293-13298
33. Berridge, M.J. (2010) Calcium hypothesis of Alzheimer's disease. Pflügers Arch. 459, 441-449
34. Berridge, M.J. (2011) Calcium signalling and Alzheimer's disease. Neurochem. Res. 36, 1149-1156
35. Ross, C.A., Margolis, R.L., Reading, S.A.J., Pletnikov, M. and Coyle, J.T. (2006) Neurobiology of schizophrenia. Neuron 52, 139-153 (Pubitemid 44466356)
36. Lee, K-H., Williams, L.M., Breakspear, M. and Gordon, E. (2003) Synchronous γ activity: a review and contribution to an integrative neuroscience model of schizophrenia. Brain Res. Rev. 41, 57-38
37. Meyer-Lindenberg, A. (2010) From maps to mechanisms through neuroimaging of schizophrenia. Nature 468, 194-202
38. Uhlhaas, P.J. and Singer, W. (2010) Abnormal neural oscillations and synchrony in schizophrenia. Nat. Rev. Neurosci. 11, 100-113
39. Coyle, J.T. (2006) Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell. Mol. Neurobiol. 26, 363-382
40. Kantrowitz, J.T. and Javitt, D.C. (2010) N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? Brain Res. Bull. 83, 108-121
41. Pitcher, G.M., Kalia, L.V., Ng, D., Goodfellow, N.M., Yee, K.T., Lambe, E.K. and Salter, M.W. (2011) Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors. Nat. Med. 17, 470-478
42. Li, X. and Jope, R.S. (2010) Is glycogen synthase kinase-3 a central modulator of mood regulation? Neuropsychopharmacology 35, 2143-2154
43. Chumakov, I., Blumenfeld, M., Guerassimenko, O., Cavarec, L., Palicio, M., Abderrahim, H., Bougueleret, L., Barry, C., Tanaka, H., La Rosa, P. et al. (2002) Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 99, 13675-13680
44. Behrens, M.M. and Sejnowski, T.J. (2009) Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex? Neuropharmacology 57, 193-200
45. Do, K.Q., Cabungcal, J.H., Frank, A., Steullet, P. and Cuenod, M. (2009) Redox dysregulation, neurodevelopment, and schizophrenia. Curr. Opin. Neurobiol. 19, 220-230
46. Hardingham, G.E. and Bading, H. (2010) Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat. Rev. Neurosci. 11, 682-696
47. Berk, M., Ng, F., Dean, O., Dodd, S. and Bush, A.I. (2008) Glutathione: a novel treatment target in psychiatry. Trends Pharmacol. Sci. 29, 346-351
48. Vacic, V., McCarthy, S., Malhotra, D., Murray, F., Chou, H.-H., Peoples, A., Makarov, V., Yoon, S., Bhandari, A., Corominas, R. et al. (2011) Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia. Nature 471, 499-503
49. Lawrence, J.J. (2008) Cholinergic control of GABA release: emerging parallels between neocortex and hippocampus. Trends Neurosci. 31, 317-327
50. Sharma, G. and Vijayaraghavan, S. (2003) Modulation of presynaptic store calcium induces release of glutamate and postsynaptic firing. Neuron 38, 929-939 (Pubitemid 36789765)
51. Fisahn, A., Yamada, M., Duttaroy, A., Gan, J.-W., Deng, C.-X., McBain, C.J. and Wess, J. (2002) Muscarinic induction of hippocampal γ oscillations requires coupling of the M1 receptor to two mixed cation currents. Neuron 33, 615-624 (Pubitemid 34188436)
52. 2 dopamine receptor. J. Neurosci. 22, 8476-8486
53. Koh, P.O., Undie, A.S., Kabbani, N., Levenson, R., Goldman-Rakic, P.S. and Lidow, M.S. (2003) Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients. Proc. Natl. Acad. Sci. U.S.A. 100, 313-317
54. 3 receptor activity is inhibited by therapeutic levels of lithium. J. Clin. Invest. 116, 1668-1674
55. Quiroz, J.A., Machado-Vieira, R., Zarate, C.A. and Manji, H.K. (2010) Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects. Neuropsychobiology 62, 50-60
56. Li, X. and Jope, R.S. (2010) Is glycogen synthase kinase-3 a central modulator in mood regulation? Neuropsychopharmacology 35, 2143-2154
57. Machado-Vieira, R., Pivovarova, N.B., Stanika, R.I., Yun Wang, P.Y., Zhou, R., Zarate, C.A., Drevets, W.C., Brantner, C.A., Baum, A., Laje, G. et al. (2011) The Bcl-2 gene polymorphism rs956572AA increases inositol 1,4,5-trisphosphate receptor-mediated endoplasmic reticulum calcium release in subjects with bipolar disorder. Biol. Psychiatry 69, 344-352
58. Warsh, J.J., Andreopoulos, S. and Li, P.P. (2004) Role of intracellular calcium signaling in the pathophysiology and pharmacotherapy of bipolar disorder: current status. Clin. Neurosci. Res. 4, 201-213
59. Berridge, M.J., Downes, C.P. and Hanley, M.R. (1989) Neural and developmental actions of lithium: a unifying hypothesis. Cell 59, 411-419 (Pubitemid 19284456)
60. Baum, A.E., Akula, N., Cabanero, M., Cardona, I., Corona, W., Klemens, B., Schulze, T.G., Cichon, S., Rietschel, M., Nöthen, M.M. et al. (2008) A genome-wide association study implicates diacylglycerol kinase η (DGKH) and several other genes in the etiology of bipolar disorder. Mol. Psychiatry 13, 197-207
61. 1-mediated neurite retraction. Mol. Biol. Cell 17, 1834-1844
62. 2 dopamine receptor. J. Neurosci. 22, 8476-8486